Evidence map›Paper›PMID 18160535›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

Three-dimensional cellular microarray for high-throughput toxicology assays.

Moo-Yeal Lee, R Anand Kumar, Sumitra M Sukumaran, Michael G Hogg, Douglas S Clark, Jonathan S Dordick

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Bioinformatics Study of Flavonoids From GenusAdvances and applications in bioinformatics and chemistry : AABC · 2024
    Article
  6. Article
  7. Application of microfluidic chips in anticancer drug screening.Bosnian journal of basic medical sciences · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Moo-Yeal LeeSolidus Biosciences, Inc., Troy, NY 12180, USA.
R Anand Kumar
Sumitra M Sukumaran
Michael G Hogg
Douglas S Clark
Jonathan S Dordick

Funding

Integrated Biochip for In-Vitro ToxicologyR42ES012619 · NIEHS · SOLIDUS BIOSCIENCES, INC. · PI DORDICK, JONATHAN S. · 2005 to 2007
$1.7M
Integrated Biochip for In-Vitro ToxicologyR41ES012619 · NIEHS · SOLIDUS BIOSCIENCES, INC. · PI DORDICK, JONATHAN S. · 2003 to 2004
$499k
NIEHS NIH HHS ES-012619NIEHS NIH HHS R41 ES012619NIEHS NIH HHS R42 ES012619
6 · The paper itself

Abstract

We have developed a miniaturized 3D cell-culture array (the Data Analysis Toxicology Assay Chip or DataChip) for high-throughput toxicity screening of drug candidates and their cytochrome P450-generated metabolites. The DataChip consists of human cells encapsulated in collagen or alginate gels (as small as 20 nl) arrayed on a functionalized glass slide for spatially addressable screening against multiple compounds. A single DataChip containing 1,080 individual cell cultures, used in conjunction with the complementary human P450-containing microarray (the Metabolizing Enzyme Toxicology Assay Chip or MetaChip), simultaneously provided IC(50) values for nine compounds and their metabolites from CYP1A2, CYP2D6, and CYP3A4 and a mixture of the three P450s designed to emulate the human liver. Similar responses were obtained with the DataChip and conventional 96-well plate assays, demonstrating that the near 2,000-fold miniaturization does not influence the cytotoxicity response. The DataChip may therefore enable toxicity analyses of drug candidates and their metabolites at throughputs compatible with the availability of compounds at early-stage drug discovery.

Indexed as

AnimalsCell Line, TumorChemistry, PharmaceuticalCollagenCytochrome P-450 CYP1A2Cytochrome P-450 CYP2D6Cytochrome P-450 CYP3ACytochrome P-450 Enzyme SystemDrug DesignEquipment DesignHumansInhibitory Concentration 50Oligonucleotide Array Sequence AnalysisPharmacogeneticsRatsTechnology, PharmaceuticalCollagenCYP3A4 protein, humanCytochrome P-450 CYP1A2Cytochrome P-450 CYP2D6Cytochrome P-450 CYP3ACytochrome P-450 Enzyme System

Identifiers

PMID18160535
PMCPMC2224231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.